$YCBDJul 24, 2026, 5:43 PMAI processed
cbdMD (YCBD) backs bipartisan bill to preserve full‐spectrum CBD access
AI Summary
CbdMD (YCBD) said it supports the bipartisan Lawful Hemp Protection Act, introduced July 21, which would repeal a FY2026 provision that narrows the federal hemp definition on Nov. 12, 2026, and create a long‐term federal regulatory framework for hemp‐derived products. The company highlighted bill provisions — FDA oversight, mandatory third‐party testing, clearer labeling, a 21+ purchase age, domestic sourcing and limits on synthetic cannabinoids — and said passage would protect lawful full‐spectrum CBD from being removed and provide regulatory certainty for manufacturers and retailers.
Positives
- Public support for the Lawful Hemp Protection Act could help protect market access for full‑spectrum CBD if the bill advances
- Bill proposes FDA oversight, mandatory third‑party testing, transparent labeling and 21+ requirement, which would create clearer compliance rules for producers
- There is a looming Nov. 12, 2026 deadline when the hemp definition would narrow, giving near‑term urgency to legislative action
Negatives
- Legislation is pending and outcome is uncertain — advocacy does not guarantee Congress will act
- If Congress fails to act, Section 781’s narrowed hemp definition could remove many lawful products from the market on Nov. 12, 2026
- Proposed requirements (testing, domestic sourcing, age restrictions) could raise compliance costs for producers and retailers